QB3 Overview

  • Investor Type

  • Accelerator/​Incubator

  • Status

  • Active

  • Professionals

  • 6

Professionals
  • Investments

  • 411

  • Portfolio

  • 266

  • Exits

  • 137

Exits

QB3 General Information

Description

Founded in 2000, California Institute for Quantitative Biosciences is an accelerator and incubator firm based in San Francisco, California.The firm seeks investments in acceleration and incubation, seed, and early stage companies. The firm prefers to make investments in bioeconomy sector.

Contact Information

Website
www.qb3.org
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Other Investor Types
Venture Capital
VC-Backed Company
Primary Office
  • Suite 214, Byers Hall
  • UCSF Mission Bay, 1700 4th Street
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

QB3 Investments (411)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Iaterion 11-Jan-2022 Seed Round Drug Discovery Pre-Clinical Trials
0000 00000000000 01-Oct-2021 00000 00000 00.00 Drug Discovery Generating Revenue
0000000 (00000 000 10-Jun-2021 000000000000 Other Devices and Supplies Generating Revenue
00000000 0000000 07-May-2021 00000 00000 00.00 Monitoring Equipment Clinical Trials - General
0000 0000 0000000 18-Dec-2020 00000 00000 00.00 Surgical Devices Generating Revenue
0000000000 0000000 01-Nov-2020 0000 00000 00.00 Drug Discovery Generating Revenue
00000000 08-Nov-2019 000000000000 Drug Discovery Clinical Trials - Phase 2 000000000 000000
00000 (0000 000000 08-Nov-2019 000000000000 Drug Discovery Clinical Trials - Phase 1 000000000 000000
OralOme 21-Oct-2019 Accelerator/Incubator Drug Discovery Out of Business
Yubersci 23-Sep-2019 Accelerator/Incubator Other Commercial Services Stealth
You’re viewing 10 of 411 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QB3 Exits (137)

Company Name Exit Date Exit Type Exit Size
Miroculus 15-Mar-2023 Merger/Acquisition
00000 000000000000 22-Jan-2023 000 00 00000000
000000 000 01-Jan-2023 000 00 00000000
000000000 01-Jan-2023 000000000 00000000
000000 15-Nov-2022 000000000000000000
0000 000000000000 12-Oct-2022 000 00 00000000
0000000 03-Oct-2022 000000000000000000
000000 0000000 31-Aug-2022 0000000 000000
Boolean Biotech 22-Aug-2022 Out of Business
LTP NeuroMed 07-Aug-2022 Out of Business
You’re viewing 10 of 137 exits. Get the full list »

QB3 Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

QB3 Team (11)

Name Title Deals Funds Boards Office
Nevan Krogan Ph.D Director San Francisco, CA
Susan Marqusee Ph.D Director Berkeley, CA
Kaspar Mossman Ph.D Director of Communications and Marketing 0 San Francisco, CA
David Haussler Ph.D Director, QB3-UCSC; Scientific Santa Cruz, CA
Regis Kelly Ph.D Executive Director 0 San Francisco, CA
You’re viewing 5 of 11 team members. Get the full list »